Open AccessThis article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are Cell Cycle inhibitor credited. References 1. Global Initiative for Asthma (GINA). National Heart Lung and Blood Institute, National Institutes of Health. GINA report. Global strategy for asthma management and prevention. Bethesda, NIH Publication Number 02-3659. 2012. http://​www.​ginasthma.​com. 2. Global Initiative

for Chronic Obstructive Lung Disease (GOLD). National Heart Lung and Blood Institute, National Institutes of Health. GOLD report. Global strategy for diagnosis, management and prevention of COPD. Bethesda, NIH 2009. 2012. http://​www.​goldcopd.​org. 3. Löfdahl C-G, Svedmyr N. Formoterol fumarate, a new beta 2-adrenoceptor agonist: acute studies on selectivity Bioactive Compound Library supplier and duration of effect after inhaled and oral administration. Allergy. 1989;44(4):264–71.PubMedCrossRef 4. Laube BL, Janssens HM, de Jongh FHC, Devadason SG, Dhand R, Diot P, et al. What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J. 2011;37(6):1308–31.PubMedCrossRef 5. van der Palen J, Klein JJ, van Herwaarden CLA, Zielhuis GA, Seydel ER. Multiple inhalers confuse asthma https://www.selleckchem.com/products/sn-38.html patients.

Eur Respir J. 1999;14(5):1034–7.PubMedCrossRef 6. Lavorini F, Magnan A, Dubus JC, Voshaar T, Corbetta L, Broeders M, et al. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med. 2008;102(4):593–604.PubMedCrossRef 7. Selroos O, Pietinalho A, Riska H. Delivery devices for inhaled asthma medication: clinical implications of differences in effectiveness. Clin Immunother. 1996;6(4):273–99.CrossRef Methamphetamine 8. Brocklebank D, Ram F, Wright J, Barry P,

Cates C, Davies L, et al. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airway disease: a systematic review of the literature. Health Technol Assess. 2001;5(26):1–149.PubMed 9. Dolovich MB, Ahrens RC, Hess DR, Anderson P, Dhand R, Rau JL, et al. Device selection and outcomes of aerosol therapy: evidence-based guidelines. American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest. 2005;127(1):335–71.PubMedCrossRef 10. Rabe KF, Vermeire PA, Soriano JB, Maier WC. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J. 2000;16(5):802–27.PubMedCrossRef 11. Rabe KF, Adachi M, Lai CK, Soriano JB, Vermeire PA, Weiss KB, et al. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol. 2004;114(1):40–7.PubMedCrossRef 12. Lindgren S, Bake B, Larsson S. Clinical consequences of inadequate inhalation technique in asthma therapy. Eur Respir Dis. 1987;70(2):93–8. 13. Giraud V, Roche N.